Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 985347

Dimethyl fumarate, a two-edged drug: Current status and future directions


Saidu, Nathaniel Edward Bennett; Kavian, Niloufar; Leroy, Karen; Jacob, Claus; Nicco, Carole; Batteux, Frédéric; Alexandre, Jérôme
Dimethyl fumarate, a two-edged drug: Current status and future directions // Medicinal Research Reviews, 39 (2019), 2; 1-30 doi:10.1002/med.21567 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 985347 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Dimethyl fumarate, a two-edged drug: Current status and future directions

Autori
Saidu, Nathaniel Edward Bennett ; Kavian, Niloufar ; Leroy, Karen ; Jacob, Claus ; Nicco, Carole ; Batteux, Frédéric ; Alexandre, Jérôme

Izvornik
Medicinal Research Reviews (0198-6325) 39 (2019), 2; 1-30

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
DJ-1 ; cancer ; dimethyl fumarate ; immunomodulation ; nuclear factor erythroid 2 (NF-E2)-related factor 2 ; oxidative stress ; succinic-GSH

Sažetak
Dimethyl fumarate (DMF) is a fumaric acid ester registered for the treatment of relapsing- remitting multiple sclerosis (RRMS). It induces protein succination leading to inactivation of cysteine-rich proteins. It was first shown to possess cytoprotective and antioxidant effects in noncancer models, which appeared related to the induction of the nuclear factor erythroid 2 (NF-E2)-related factor 2 (NRF2) pathway. DMF also displays antitumor activity in several cellular and mice models. Recently, we showed that the anticancer mechanism of DMF is dose- dependent and is paradoxically related to the decrease in the nuclear translocation of NRF2. Some other studies performed indicate also the potential role of DMF in cancers, which are dependent on the NRF2 antioxidant and cellular detoxification program, such as KRAS-mutated lung adenocarcinoma. It, however, seems that DMF has multiple biological effects as it has been shown to also inhibit the transcription factor nuclear factor kappa-light-chain- enhancer of activated B cells (NF-κB), thus blocking downstream targets that may be involved in the development and progression of inflammatory cascades leading to various disease processes, including tumors, lymphomas, diabetic retinopathy, arthritis, and psoriasis. Herein, we present the current status and future directions of the use of DMF in various diseases models with particular emphases on its targeting of specific intracellular signal transduction cascades in cancer ; to shed some light on its possible mode of action.

Izvorni jezik
Engleski

Znanstvena područja
Biologija



POVEZANOST RADA


Ustanove:
Institut "Ruđer Bošković", Zagreb

Citiraj ovu publikaciju

Saidu, Nathaniel Edward Bennett; Kavian, Niloufar; Leroy, Karen; Jacob, Claus; Nicco, Carole; Batteux, Frédéric; Alexandre, Jérôme
Dimethyl fumarate, a two-edged drug: Current status and future directions // Medicinal Research Reviews, 39 (2019), 2; 1-30 doi:10.1002/med.21567 (međunarodna recenzija, pregledni rad, znanstveni)
Saidu, N., Kavian, N., Leroy, K., Jacob, C., Nicco, C., Batteux, F. & Alexandre, J. (2019) Dimethyl fumarate, a two-edged drug: Current status and future directions. Medicinal Research Reviews, 39 (2), 1-30 doi:10.1002/med.21567.
@article{article, year = {2019}, pages = {1-30}, DOI = {10.1002/med.21567}, keywords = {DJ-1, cancer, dimethyl fumarate, immunomodulation, nuclear factor erythroid 2 (NF-E2)-related factor 2, oxidative stress, succinic-GSH}, journal = {Medicinal Research Reviews}, doi = {10.1002/med.21567}, volume = {39}, number = {2}, issn = {0198-6325}, title = {Dimethyl fumarate, a two-edged drug: Current status and future directions}, keyword = {DJ-1, cancer, dimethyl fumarate, immunomodulation, nuclear factor erythroid 2 (NF-E2)-related factor 2, oxidative stress, succinic-GSH} }
@article{article, year = {2019}, pages = {1-30}, DOI = {10.1002/med.21567}, keywords = {DJ-1, cancer, dimethyl fumarate, immunomodulation, nuclear factor erythroid 2 (NF-E2)-related factor 2, oxidative stress, succinic-GSH}, journal = {Medicinal Research Reviews}, doi = {10.1002/med.21567}, volume = {39}, number = {2}, issn = {0198-6325}, title = {Dimethyl fumarate, a two-edged drug: Current status and future directions}, keyword = {DJ-1, cancer, dimethyl fumarate, immunomodulation, nuclear factor erythroid 2 (NF-E2)-related factor 2, oxidative stress, succinic-GSH} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font